We believe that the final disclosure of the pathological effects of the tau protein in an ischemic brain and post-ischemia and the influence of ischemia on tau protein phosphorylation may lead to the development of a possible innovative target for post-ischemic brain treatment. This evidence concerns the gene MAPT and ischemia.